価格表

在庫・価格 : 2025年05月01日 12時26分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SOX11, Rabbit-Poly
データシート
NBP1-85823 NOVノバス バイオロジカルス
Novus biologicals, LLC
100 μl ¥132,000
(未発注)
追加

在庫・価格 : 2025年05月01日 12時26分 現在

Anti-SOX11, Rabbit-Poly

  • 商品コード:NBP1-85823
  • メーカー:NOV
  • 包装:100μl
  • 価格: ¥132,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Ondrejka SL et al. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica 2011 Aug;96(8):1121-7
Ondrejka SL et al
2011/01/01
PubMed
2 Sernbo S et al. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer 2011;11:405
Sernbo S et al
2011/01/01
PubMed
3 Ek S et al. From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol. Cell Proteomics 2006 Jun;5(6):1072-81
Ek S et al
2006/01/01
PubMed
4 Kimura Y et al. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index. Cancer Sci. 2011 Sep;102(9):1734-41
Kimura Y et al
2011/01/01
PubMed
5 Chen YH et al. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod. Pathol. 2010 Jan;23(1):105-12
Chen YH et al
2010/01/01
PubMed
6 Dictor M et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 2009 Nov;94(11):1563-8
Dictor M et al
2009/01/01
PubMed
7 Wang X et al. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma. PLoS ONE 2010;5(11):e14085
Wang X et al
2010/01/01
PubMed
8 Wang X et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br. J. Haematol. 2008 Oct;143(2):248-52
Wang X et al
2008/01/01
PubMed
9 Carvajal-Cuenca A et al. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 2012 Feb;97(2):270-8
Carvajal-Cuenca A et al
2012/01/01
PubMed
10 Gustavsson E et al. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol. Cancer 2010;9:187
Gustavsson E et al
2010/01/01
PubMed
11 Mozos A et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 2009 Nov;94(11):1555-62
Mozos A et al
2009/01/01
PubMed
12 Aiden AP et al. Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network. Cell Stem Cell 2010 Jun;6(6):591-602
Aiden AP et al
2010/01/01
PubMed
13 Ek S et al. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 2008 Jan;111(2):800-5
Ek S et al
2008/01/01
PubMed
14 Cao X et al. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases. Med. Oncol. 2012 Jun;29(2):1190-6
Cao X et al
2012/01/01
PubMed
15 Nygren L et al. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood 2012 May;119(18):4215-23
Nygren L et al
2012/01/01
PubMed
16 Fernàndez V et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010 Feb;70(4):1408-18
Fernàndez V et al
2010/01/01
PubMed
17 Kuo PY et al. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Oncogene 2015 Mar;34(10):1231-40
Kuo PY et al
2015/01/01
PubMed
18 Ribera-Cortada I et al. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Mod. Pathol. 2015 Nov;28(11):1435-47
Ribera-Cortada I et al
2015/01/01
PubMed
19 Davidson B et al. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum. Pathol. 2015 Jan;46(1):1-8
Davidson B et al
2015/01/01
PubMed
20 Righi S et al. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients. Hum. Pathol. 2017 01;59:94-101
Righi S et al
2017/01/01
IHC PubMed
  • No.: 1
  • 文献情報:
    Ondrejka SL et al. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica 2011 Aug;96(8):1121-7
    Ondrejka SL et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sernbo S et al. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer 2011;11:405
    Sernbo S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ek S et al. From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol. Cell Proteomics 2006 Jun;5(6):1072-81
    Ek S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kimura Y et al. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index. Cancer Sci. 2011 Sep;102(9):1734-41
    Kimura Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Chen YH et al. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms. Mod. Pathol. 2010 Jan;23(1):105-12
    Chen YH et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Dictor M et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 2009 Nov;94(11):1563-8
    Dictor M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Wang X et al. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma. PLoS ONE 2010;5(11):e14085
    Wang X et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wang X et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br. J. Haematol. 2008 Oct;143(2):248-52
    Wang X et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Carvajal-Cuenca A et al. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 2012 Feb;97(2):270-8
    Carvajal-Cuenca A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Gustavsson E et al. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol. Cancer 2010;9:187
    Gustavsson E et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Mozos A et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 2009 Nov;94(11):1555-62
    Mozos A et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Aiden AP et al. Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network. Cell Stem Cell 2010 Jun;6(6):591-602
    Aiden AP et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Ek S et al. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 2008 Jan;111(2):800-5
    Ek S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Cao X et al. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases. Med. Oncol. 2012 Jun;29(2):1190-6
    Cao X et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Nygren L et al. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood 2012 May;119(18):4215-23
    Nygren L et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Fernàndez V et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010 Feb;70(4):1408-18
    Fernàndez V et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Kuo PY et al. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Oncogene 2015 Mar;34(10):1231-40
    Kuo PY et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Ribera-Cortada I et al. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Mod. Pathol. 2015 Nov;28(11):1435-47
    Ribera-Cortada I et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Davidson B et al. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum. Pathol. 2015 Jan;46(1):1-8
    Davidson B et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Righi S et al. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients. Hum. Pathol. 2017 01;59:94-101
    Righi S et al
    2017/01/01
  • 備考:
    IHC
  • 参照:
    PubMed